Management is buying the same thing twice: proven demand from one place is being replicated into identified new places r
The model's full reasoning — Q3 2022 call → NOWe need to determine if management describes the company as currently in the middle of copying a part of its own business that is already working into additional places where the same demand is already visible. The key is: a proven instance, copies being stood up now, and demand already identified at the destination. Scanning the transcript, management discusses various initiatives: growth in healthcare, renewable energy, affordable housing, Laurel Road expansion, GradFin acquisition, etc. But does any of these fit the pattern of a proven instance being replicated with visible demand? Chris Gorman mentions: "We continue to make tangible progress against the three commitments we announced earlier this year at our Investor Day. These goals for 2025 are as follows, growing relationship households in our consumer business by 20%, growing our senior bankers by 25%, and growing our Laurel Road member households to 250,000 from 50,000. We are on pace to achieve all three measures. We have grown consumer households and Laurel Road members, as well as the number of our senior bankers, although our senior banker hires have been slower in the back half of this year, reflecting current market conditions." This is about growth targets, not necessarily replicating a proven unit. Laurel Road is a business that has been operating, and they are expanding it to include nurses. They mention: "In healthcare, we are growing relationships with significant healthcare providers and expanding our Laurel Road business, including our recent market extension to include nurses." That could be seen as copying a proven business (Laurel Road for doctors) into a new customer segment (nurses). But is that a "copy" of a proven instance? Laurel Road has been proven with doctors, and they are extending to nurses. Is that a new instance? Possibly. But does management describe it as currently standing up copies? They say "expanding our Laurel Road business, including our recent market extension to include nurses." That suggests they have already extended to nurses. But is that a separate instance? It's more of a product expansion to a new customer type. Also, is demand already visible? They mention "pre-qualified prudential prospects" from GradFin consultations.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| VSEC | VSE Corporation | Q3 2022 | 2022-10-28 | B+ |
| FSLR | First Solar, Inc. | Q3 2022 | 2022-10-28 | C+ |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| GDS | GDS Holdings Limited | Q2 2021 | 2021-08-17 | C+ |
| TPIC | TPI Composites, Inc. | Q3 2018 | 2018-11-11 | C |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| FOLD | Amicus Therapeutics, Inc. | Q1 2018 | 2018-05-08 | C+ |
| AOSL | Alpha and Omega Semiconductor Limited | Q2 2018 | 2018-02-07 | B |
| VSAT | Viasat, Inc. | Q4 2017 | 2017-05-23 | C+ |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
GDS · Q2 2021 → YESThe question is whether management describes the company as currently in the middle of copying a part of its own business that is already working into additional places where the same demand is alread...YES The transcript shows management describing a clear, present-tense replication of their proven China-based data center platform into new markets (Hong Kong, Macau, Southeast Asia) where demand is already visible and committed. William Huang explicitly references the “proven” China edge-of-town model (land-and-expand MOUs, 500 000 sqm secured pipeline, hyperscale orders already landed) and states they are “currently developing two purpose-built data centers” in Hong Kong (HK1/HK2) with most capacity “already allocated to strategic customers pending contracts,” plus a new building (HK4) under agreement and a heads-of-agreement for HK3, creating “nearly 80 megawatts of purpose-built capacity through to 2027.” For Macau they have a JV to acquire brownfield sites for redevelopment (20 MW).
FOLD · Q1 2018 → YESThe question is about whether management describes the company as currently copying a proven part of its business into additional places where demand is already visible. YES The transcript shows management describing Galafold as a proven commercial offering (Q1 revenue $16.7M, 300% YoY growth, hundreds of patients, high compliance, 7 approvals, 18 countries with pricing/reimbursement) that is now being replicated into additional markets.
TPIC · Q3 2018 → YESThe question is whether management describes the company as currently in the middle of copying a part of its own business that is already working into additional places where the same demand is alread...YES The transcript shows management describing a proven manufacturing operation (existing dedicated lines and plants in the U.S.